Risk factors for developing diverticuli are chronic constipation and increasing age
The German BfArM and equivalent agencies (ANSM in France, AEMPS in Spain, AIFA in Italy, URPL in Poland) treat unauthorized human use of these compounds as outside the scope of the marketing authorization regime entirely
Cannabis may temporarily relieve nausea for some people, but it can also worsen digestive symptoms
Researchers frequently utilize this compound in cellular and molecular model systems to explore growth factor signaling, protein synthesis regulation, and mechanisms related to cellular growth and metabolic pathway modeling
Rybelsus has additional safety considerations including potential worsening of diabetic retinopathy (particularly with rapid improvement in blood glucose control), risk of dehydration from gastrointestinal effects, increased risk of gallbladder disease, and caution in people with severe gastrointestinal disease or gastroparesis
Routine measurement of serum calcitonin levels or thyroid ultrasound screening before starting GLP-1 therapy is not recommended in asymptomatic patients without specific risk factors